Diphenylcyclopropenone in Patients with Alopecia Areata: A Critically Appraised Topic

    October 2015 in “ British Journal of Dermatology
    Rosanna A. Kuin, Phyllis I. Spuls, Jacqueline Limpens, Esther J van Zuuren
    TLDR Diphenylcyclopropenone's effectiveness and safety for alopecia areata are unclear.
    The document concluded that there was very low quality evidence supporting the effectiveness and safety of diphenylcyclopropenone in treating extensive resistant alopecia areata. It emphasized the need for well-designed and well-conducted randomized controlled trials with comprehensive reporting and high-quality methodological descriptions to better assess the treatment's efficacy and safety.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Research

    6 / 6 results